The board of directors of Synthetic Biologics, Inc (NYSEMKT:SYN) determined to hold its 2014 Annual Meeting of Stockholders (the “Annual Meeting”) on June 10, 2014. The record date, time and location of the Annual Meeting will be as set forth in the Company’s proxy statement for the Annual Meeting. Synthetic Biologics Inc (NYSEMKT:SYN) stock performance was 5.98% in last session and finished the day at $2.48. Traded volume was 1,718,100 million shares in the last session and the average volume of the stock remained 1.35 million shares. The beta of the stock remained 1.28. Synthetic Biologics Inc (NYSEMKT:SYN) insider ownership is 16.72%.
GTT Communications, Inc. (NYSEMKT:GTT) issued a press release relating to the fourth quarter and year ended December 31, 2013 financial results. GTT Communications Inc (NYSEMKT:GTT) rose 10.55 percent to $10.79 yesterday on volume of 65,489.00 million shares. The intra-day range of the stock was $9.87 to $10.94. GTT Communications Inc (NYSEMKT:GTT) has a market capitalization of $254.81 million.
Golden Enterprises, Inc. (NASDAQ:GLDC)’s Board of Directors today declared a quarterly dividend of $.03125 per share payable April 23, 2014 to stockholders of record on April 14, 2014. Golden Enterprises, Inc. (NASDAQ:GLDC)’s stock on April 10, 2014 reported a increase of 6.75% to the closing price of $4.45. Its fifty two weeks range is $3.33 -$4.57. The total market capitalization recorded $52.21 million. The overall volume in the last trading session was 16,300 million shares. In its share capital, Golden Enterprises, Inc. (NASDAQ:GLDC) has 11.73 million outstanding shares.
NanoViricides, Inc. (NYSEMKT:NNVC) announced that Anil R. Diwan, Ph.D., President, Chairman, and co-Founder of the Company was recognized as the “2014 Researcher of the Year” by BusinessNewHaven, a business journal, and New Haven Magazine, publications that serve the state of Connecticut. On Thursday, shares of NanoViricides Inc (NYSEMKT:NNVC) advanced 9.01% to close the day at $ 3.51. Its monthly performance is recorded as -9.77 %. NanoViricides Inc (NYSEMKT:NNVC) quarterly revenue growth is -29.38 %.